Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment

Summary Background Conventional treatment of basal cell carcinoma (BCC) causes morbidity and/or disfigurement in some patients because of the location (e.g. mid‐face) and size of the lesion. Objectives Following reports that such difficult‐to‐treat BCC lesions have been treated successfully with t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2003-12, Vol.149 (6), p.1242-1249
Hauptverfasser:	Horn, M., Wolf, P., Wulf, H.C., Warloe, T., Fritsch, C., Rhodes, L.E., Kaufmann, R., De Rie, M., Legat, F.J., Stender, I.M., Solér, A.M., Wennberg, A-M., Wong, G.A.E., Larkö, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Topical Adult Aged Aged, 80 and over Aminolevulinic Acid - administration & dosage Aminolevulinic Acid - analogs & derivatives basal cell carcinoma Biological and medical sciences Carcinoma, Basal Cell - drug therapy cosmetic results Dermatology Diseases of the skin. Cosmetics Female Follow-Up Studies Humans Male Medical sciences methyl aminolaevulinate Middle Aged Photochemotherapy photodynamic therapy Photosensitizing Agents - administration & dosage Prospective Studies Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Recurrence Skin Neoplasms - drug therapy Treatment Outcome Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!